StockMarketWire.com - Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC [LON:HIK] and cut its price target to 2240p (from 2310p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk